SANUWAVE Health, Inc.
SNWV
$29.89
-$1.06-3.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.46% | 47.64% | 88.98% | 53.20% | 53.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.46% | 47.64% | 88.98% | 53.20% | 53.27% |
| Cost of Revenue | 23.61% | 5.84% | 62.39% | 59.90% | 25.52% |
| Gross Profit | 75.73% | 66.31% | 99.58% | 50.88% | 67.21% |
| SG&A Expenses | 22.23% | 48.50% | 27.61% | 29.65% | 17.65% |
| Depreciation & Amortization | 5.49% | 16.93% | 10.16% | -3.74% | -3.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.24% | 31.05% | 35.07% | 38.09% | 18.82% |
| Operating Income | 193.90% | 142.73% | 467.80% | 113.96% | 46.92% |
| Income Before Tax | -25.35% | -169.75% | 12.84% | 190.35% | 65.38% |
| Income Tax Expenses | -- | 575.00% | -- | -- | -- |
| Earnings from Continuing Operations | -25.35% | -169.91% | 12.84% | 190.35% | 65.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.35% | -169.91% | 12.84% | 190.35% | 65.38% |
| EBIT | 193.90% | 142.73% | 467.80% | 113.96% | 46.92% |
| EBITDA | 230.74% | 127.74% | 930.45% | 89.89% | 46.83% |
| EPS Basic | 54.55% | -124.92% | 34.84% | 144.49% | 82.87% |
| Normalized Basic EPS | 53.47% | -127.05% | 34.84% | 108.48% | 83.27% |
| EPS Diluted | 54.55% | -124.92% | 34.84% | 137.91% | 82.87% |
| Normalized Diluted EPS | 53.47% | -127.05% | 34.84% | 107.23% | 83.27% |
| Average Basic Shares Outstanding | 175.79% | 180.57% | 33.77% | 103.08% | 102.12% |
| Average Diluted Shares Outstanding | 175.79% | 180.57% | 33.77% | 138.30% | 102.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |